Ditemukan 15 dokumen yang sesuai dengan query :: Simpan CSV
Marco Villa, Steven Black, Nicola Groth, Kenneth J. Rothman, Giovanni Apolone, Noel S. Weiss, Ivana Aquino, Liana Boldori, Fausta Caramaschi, Antonio Gattinoni, Giancarlo Malchiodi, Antonio Crucitti, Giovanni Della Cioppa, Elio Scarpini, Domenico Mavilio, Salvatore Mannino
Abstrak:
MF59-adjuvanted trivalent influenza vaccine (Novartis Vaccines and Diagnostics, Siena, Italy) has been shown to be more effective than nonadjuvanted vaccine in the elderly population. Here we present results from a large-scale, observational, noninterventional, prospective postlicensure study that evaluated the safety of MF59-adjuvanted vaccine in elderly subjects aged 65 years or more. The study was performed in 5 northern Italian health districts during the 2006-2007, 2007-2008, and 2008-2009 influenza seasons. The choice of vaccine-either adjuvanted vaccine or a nonadjuvanted influenza vaccine-was determined by individual providers on the basis of local influenza vaccination policy. Hospitalizations for potential adverse events of special interest (AESIs) were identified from hospital databases and then reviewed against recognized case definitions to identify confirmed cases of AESI. Cumulative incidences were calculated for AESIs in predefined biologically plausible time windows, as well as in a 6-month window following vaccination. During the 3-year study period, 170,988 vaccine doses were administered to a total of 107,661 persons. Despite the large study size, cases of AESI resulting in hospitalization were rare, and risks of AESI were similar in both the MF59-adjuvanted and nonadjuvanted vaccination groups. In conclusion, similar safety profiles were observed for both nonadjuvanted and MF59-adjuvanted seasonal influenza vaccines in elderly recipients.
Read More
AJE Vol.178, No.7
Oxford : Oxford University Press, 2013
Indeks Artikel Jurnal-Majalah Pusat Informasi Kesehatan Masyarakat
☉
Anggita Bunga Anggraini, Nyoman Fitri
HSJI Vol. 6, No. 2
Jakarta : Lembaga Penerbit Balitbangkes NIHRD, 2015
Indeks Artikel Jurnal-Majalah Pusat Informasi Kesehatan Masyarakat
☉
Yeliastuti Ike Marliana, Muhammad Atoillah Isfandiari
JBE Vol.1, No.1
Surabaya : FKM Unair, 2013
Indeks Artikel Jurnal-Majalah Pusat Informasi Kesehatan Masyarakat
☉
Muh Agung S; Pembimbing: Ella Nurlaella Hadi; Penguji: Tri Yunis Miko Wahyono, Wahyu Septiono, Saepul Anwar, Vivi Voronika
Abstrak:
Read More
Rendahnya cakupan imunisasi polio di Indonesia menimbulkan kembalinya penyakit polio dengan 12 kasus terkonfirmasi. Munculmya kasus tersebut ditetapkan sebagai Kejadian Luar Biasa (KLB), terdapat 32 provinsi dan 399 kabupaten/kota berisiko tinggi terhadap polio. Salah satu hambatan utama adalah keraguan masyarakat terhadap status kehalalan vaksin, khususnya di wilayah dengan tingkat pengaruh islam yang kuat. Penelitian ini bertujuan mengeksplorasi hambatan dan tantangan promosi vaksinasi polio serta bentuk kerjasama multisektoral dalam mengatasi keraguan terhadap vaksin halal. Penelitian dilakukan dengan pendekatan kualitatif menggunakan desain fenomenologi, melalui wawancara mendalam terhadap tiga belas informan yang berasal dari kementerian dan lembaga pemerintah, organisasi keagamaan, perusahaan vaksin, peneliti, dan pegiat media sosial. Data dianalisis menggunakan analisis isi dengan pendekatan Social Ecological Model (SEM). Hasil penelitian menunjukkan bahwa pada tingkat individu, muncul sikap penolakan vaksin, hoaks, dan keraguan terhadap ketidakpastian status halal. Pada level interpersonal budaya patriarki dan ritual keagamaan bepengaruh terhadap penerimaan vaksinasi, sedangkan tokoh agama memiliki peran strategis dalam meningkatkan kepercayaan. Pada level komunitas, interaksi antar organisasi dan Lembaga sudah menunjukkan tren yang baik meskipun masih ditemukan tantangan. Pada level institusi dan sistem, tantangan mencakup kurangnya transparansi proses sertifikasi halal, diseminasi informasi yang belum merata, serta koordinasi antarinstansi yang belum optimal. Penelitian ini menyarankan pentingnya sinergi antar pemangku kepentingan dalam strategi promosi vaksinasi, penguatan komunikasi berbasis budaya dan agama, serta transparansi sertifikasi halal yang mudah dipahami masyarakat. Diharapkan hasil ini dapat menjadi rekomendasi bagi perumusan kebijakan promosi vaksin dan pengembangan vaksin halal yang lebih efektif dan inklusif.
The low coverage of polio immunisation in Indonesia has led to the re-emergence of polio, with twelve confirmed cases. These cases have been classified as an outbreak, with 32 provinces and 399 districts/cities identified as high-risk areas. A key barrier is public hesitancy regarding the halal status of vaccines, particularly in regions with high levels of religiosity. This study aims to explore the barriers and challenges in promoting polio vaccination and to examine forms of multisectoral collaboration in addressing halal-related concerns. A qualitative phenomenological design was employed, involving in-depth interviews with thirteen informants from ministries and governmental agencies, religious organisations, vaccine companies, researchers, and social media advocates. Data were analysed using content analysis, framed by the Social Ecological Model (SEM). The findings reveal that at the individual level, vaccine rejection, misinformation, and uncertainty about halal certification were prevalent. At the interpersonal level, patriarchal cultural norms and religious rituals influenced vaccine acceptance, while religious leaders played a strategic role in building public trust. At the community level, inter-organisational interactions have shown promising developments, despite persistent challenges. At the institutional and systemic levels, obstacles included lack of transparency in the halal certification process, uneven information dissemination, and suboptimal inter-agency coordination. The study underscores the importance of stakeholder synergy in vaccination promotion strategies, the reinforcement of culturally and religiously tailored communication, and the provision of clear and accessible information regarding halal certification. These findings offer critical recommendations for formulating more effective and inclusive vaccine promotion policies and developing halal-certified vaccines.
T-7344
Depok : FKM UI, 2025
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉
Dwi Meilani; Pembimbing : Evi Martha; Penguji : Hadi Pratomo, Anwar Hassan, Anjari Umarjianto, Hakimi
Abstrak:
Menurunnya cakupan vaksinasi di Indonesia diantaranya disebabkan oleh adanyakelompok yang menolak vaksinasi (Kemkes, 2014) . Belum banyak penellitiantentang penolakan vaksin pada komunitas media sosial, karenanya penelitian inidilakukan pada dua komunitas anti vaksin di facebook group. Dengan tujuanmengetahui faktor determinan perilaku penolakan vaksin untuk dapat dijadikandasar merumuskan strategi program yang efektif. Penelitian menggunakanmetode kualitatif dan teori Health Belief Model. Hasil penelitian menemukandeterminan sosio demography yang membentuk persepsi informan terhadapvaksin dan risiko penyakit serta faktor penghambat dan faktor pencetus yangmendorong perilaku penolakan vaksin. Peneliti menyarankan kepada KementerianKesehatan untuk meningkatkan kampanye vaksinasi melalui media termasukmedia sosial, melakukan riset berkelanjutan untuk pengembangan vaksin, bagitenaga kesehatan untuk meningkatkan pengetahuan dan keterampilan terkaitvaksin dan teknik komunikasi efektif.Kata Kunci : Perilaku, Penolakan Vaksin, Health Belief Model, Anti Vaksin,Media Sosial
One of the causes of declining vaccination coverage in Indonesia is the group thatrefused immunization (MoH, 2014). Not many studies on vaccine refusal onsocial media community that has been done, so this study was conducted on twoanti-vaccine communities on facebook group. With the aim of knowing thedeterminant factor rejection behavior of vaccines, that can be used as a basis toformulate an effective program strategies. Research using qualitative methodsand theoretical Health Belief Model. The results of the study found, thedeterminants of socio-demography that shape perceptions of informants to thevaccine and the risk of disease and inhibiting factors and precipitating factors thatdrive behavior vaccine refusal. Researchers suggested to the Ministry of Health toincrease the vaccination campaign through the media, including social media,conduct ongoing research on vaccine development, for health personnel toimprove their knowledge and skills related to vaccines and effectivecommunication techniques.Keywords: Behavior, Vaccine Refusal, Health Belief Model, Anti vaccine.Social Media
Read More
One of the causes of declining vaccination coverage in Indonesia is the group thatrefused immunization (MoH, 2014). Not many studies on vaccine refusal onsocial media community that has been done, so this study was conducted on twoanti-vaccine communities on facebook group. With the aim of knowing thedeterminant factor rejection behavior of vaccines, that can be used as a basis toformulate an effective program strategies. Research using qualitative methodsand theoretical Health Belief Model. The results of the study found, thedeterminants of socio-demography that shape perceptions of informants to thevaccine and the risk of disease and inhibiting factors and precipitating factors thatdrive behavior vaccine refusal. Researchers suggested to the Ministry of Health toincrease the vaccination campaign through the media, including social media,conduct ongoing research on vaccine development, for health personnel toimprove their knowledge and skills related to vaccines and effectivecommunication techniques.Keywords: Behavior, Vaccine Refusal, Health Belief Model, Anti vaccine.Social Media
T-4806
Depok : FKM-UI, 2015
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉
Yosephine Emilia Regina; Pembimbing: Putri Bungsu; Penguji: Trisari Anggondowati, Gertrudis Tandy
Abstrak:
Latar belakang: Pneumonia adalah salah satu penyebab terbesar kematian balita di Indonesia dengan angka kematian 2.200 balita tiap harinya. Imunisasi Pneumococcal Conjugate Vaccine (PCV) merupakan upaya pencegahan paling efektif terhadap pneumonia pada anak. Sejak diperkenalkan pada 2017 di Lombok dan 2019 di Bangka Belitung, imunisasi PCV telah diperluas secara bertahap ke beberapa provinsi dan resmi dimasukkan ke program imunisasi rutin nasional pada September 2022. Akan tetapi, hingga akhir 2023, cakupan imunisasi PCV lengkap pada anak di Indonesia baru mencapai 62,7%, jauh di bawah target nasional (100%). Penelitian ini bertujuan untuk menganalisis hubungan antara faktor pendukung, pendorong, dan pemungkin dengan status kelengkapan imunisasi PCV pada anak usia 12-23 bulan di Indonesia. Metode: Studi ini menggunakan desain cross-sectional dengan total sampling diperoleh 9.675 anak usia 12–23 bulan yang menjadi responden SKI 2023. Analisis dilakukan secara univariat dan bivariat menggunakan uji Chi-square dan regresi logistik sederhana. Hasil: Cakupan imunisasi PCV lengkap nasional pada anak usia 12-23 bulan adalah 32,1%. Faktor yang signifikan berasosiasi dengan kelengkapan imunisasi PCV meliputi memiliki akses ke fasilitas kesehatan yang mudah (OR = 7,71; 95% CI = 5,54-10,73), berstatus imunisasi dasar lengkap (OR = 5,87; 95% CI = 5,29-6,51), tinggal di Kep. Sunda Kecil (OR = 2,69; 95% CI = 2,03-3,56), lahir ditolong oleh tenaga kesehatan (OR = 2,62; 95% CI = 1,23-5,58), memiliki catatan imunisasi (OR = 2,18; 95% CI = 1,92-2,47), dan dilahirkan di fasilitas kesehatan (OR = 2,13; 95% CI: 1,76–2,60). Kesimpulan: Besarnya nilai odds pada anak yang memiliki akses ke fasilitas kesehatan yang mudah menyiratkan bahwa pemerintah masing-masing daerah perlu mengurangi kesenjangan akses ke layanan kesehatan seperti menambah infrastruktur kesehatan di daerah dengan akses sulit dan menyediakan subsidi transportasi atau layanan imunisasi keliling bagi masyarakat dari daerah yang sulit dijangkau.
Background: Pneumonia is one of the biggest causes of under-five deaths in Indonesia with 2,200 under-five deaths per day. Pneumococcal Conjugate Vaccine (PCV) immunization is the most effective preventive measure against childhood pneumonia. Since its introduction in 2017 in Lombok and 2019 in Bangka Belitung, PCV immunization has been gradually expanded to several provinces and was officially included in the national routine immunization program in September 2022. However, by the end of 2023, complete PCV immunization coverage among children in Indonesia will only reach 62.7%, far below the national target (100%). This study aimed to analyze the association between predisposing, reinforcing, and enabling factors with PCV immunization completeness among children aged 12-23 months in Indonesia. Methods: This study used a cross-sectional design with total sampling obtained 9,675 children aged 12-23 months who were respondents of SKI 2023. Univariate and bivariate analyses were conducted using the Chi-square test and simple logistic regression. Results: The national complete PCV immunization coverage in children aged 12-23 months was 32.1%. Factors significantly associated with PCV immunization completeness are having easy access to health facilities (OR = 7.71; 95% CI = 5.54-10.73), having complete basic immunization status (OR = 5.87; 95% CI = 5.29-6.51), living in Lesser Sunda Island (OR = 2.69; 95% CI = 2.03-3.56), was born assisted by a health worker (OR = 2.62; 95% CI = 1.23-5.58), had an immunization record (OR = 2.18; 95% CI = 1.92-2.47), and was born in a health facility (OR = 2.13; 95% CI: 1.76-2.60). Conclusion: The large odds ratio for children with easy access to health facilities implies that each local government needs to reduce disparities in access to health services such as adding health infrastructure in areas with difficult access and providing transportation subsidies or mobile immunization services for people from hard-to-reach areas.
Read More
Background: Pneumonia is one of the biggest causes of under-five deaths in Indonesia with 2,200 under-five deaths per day. Pneumococcal Conjugate Vaccine (PCV) immunization is the most effective preventive measure against childhood pneumonia. Since its introduction in 2017 in Lombok and 2019 in Bangka Belitung, PCV immunization has been gradually expanded to several provinces and was officially included in the national routine immunization program in September 2022. However, by the end of 2023, complete PCV immunization coverage among children in Indonesia will only reach 62.7%, far below the national target (100%). This study aimed to analyze the association between predisposing, reinforcing, and enabling factors with PCV immunization completeness among children aged 12-23 months in Indonesia. Methods: This study used a cross-sectional design with total sampling obtained 9,675 children aged 12-23 months who were respondents of SKI 2023. Univariate and bivariate analyses were conducted using the Chi-square test and simple logistic regression. Results: The national complete PCV immunization coverage in children aged 12-23 months was 32.1%. Factors significantly associated with PCV immunization completeness are having easy access to health facilities (OR = 7.71; 95% CI = 5.54-10.73), having complete basic immunization status (OR = 5.87; 95% CI = 5.29-6.51), living in Lesser Sunda Island (OR = 2.69; 95% CI = 2.03-3.56), was born assisted by a health worker (OR = 2.62; 95% CI = 1.23-5.58), had an immunization record (OR = 2.18; 95% CI = 1.92-2.47), and was born in a health facility (OR = 2.13; 95% CI: 1.76-2.60). Conclusion: The large odds ratio for children with easy access to health facilities implies that each local government needs to reduce disparities in access to health services such as adding health infrastructure in areas with difficult access and providing transportation subsidies or mobile immunization services for people from hard-to-reach areas.
S-11824
Depok : FKM UI, 2025
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉
Sri Karina BR Ginting; Pembimbing: Wachyu Sulistiadi; Penguji: Ede Surya Darmawan, Baequni
Abstrak:
Read More
Vaksinasi COVID-19 di Indonesia telah dilaksanakan sejak 13 Januari 2021 dan masih dilaksanakan hingga saat ini. Data capaian vaksinasi ditemukan terdapat perbedaan jumlah penerima vaksin dosis pertama dan dosis kedua. Hal ini menunjukkan terdapat masyarakat yang belum mendapatkan dosis primer lengkap. Padahal vaksin COVID-19 dapat membentuk antibodi secara optimal jika individu menerima dosis primer lengkap. Tujuan penelitian ini adalah mengetahui faktor-faktor apa saja yang berhubungan dengan kelengkapan vaksinasi COVID-19 pada masyarakat di wilayah DKI Jakarta tahun 2022. Penelitian ini menggunakan desain studi cross sectional dan melibatkan sebanyak 261 responden. Data dikumpulkan melalui pengisian kuesioner online yang selanjutnya dianalisis secara univariat dan bivariate menggunakan uji chi square dengan level kepercayaan 95%. Hasil penelitian menunjukkan kelengkapan vaksinasi COVID-19 pada masyarakat DKI Jakarta sudah divaksinasi secara lengkap (95,4%). Terdapat hubungan yang signifikan pada pengetahuan vaksinasi (POR: 8,59), persepsi manfaat vaksinasi COVID-19 (POR: 4,47), dan self efficacy dalam melakukan vaksinasi COVID-19 (POR: 4,78) dengan kelengkapan mendapatkan vaksinasi COVID-19 pada masyarakat. Pemerintah disarankan untuk melakukan reminder kembali kampanye vaksinasi COVID-19. Dinas Kesehatan disarankan untuk membuat perencanaan konten tentang COVID-19 dan vaksinasi COVID-19 yang terbaru serta fokus menyebarkan informasi melalui media sosial dan memperbaharui data capapain vaksinasi. Masyarakat disarankan untuk tetap waspada dan melaksanakan protokol kesehatan serta melakukan vaksinasi booster bagi yang belum melakukan.
The COVID-19 vaccination in Indonesia has been carried out since 13 January 2021 and is still being out today. Vaccination achievement data found that were differences in the number of recipients of the first dose of vaccine and the second dose. This data shows that there are people who have not received the primary doses completely. Even though the COVID-19 vaccine can optimally form antibodies if individuals receive the completeness of primary doses. This study aims to find out what factors are related to the completeness of COVID-19 vaccination in the community in the DKI Jakarta area in 2022. This study used a cross-sectional study design and involved 261 respondents. Data were collected through online questionnaires and then analyzed univariate and bivariate using the chi-square test. The results showed that the completeness of the COVID-19 vaccination in the people of DKI Jakarta had been completely vaccinated (95.4%). There is a significant relationship between vaccination knowledge (POR: 8,59), perceived benefits of COVID-19 vaccination (POR: 4,47), and self-efficacy in carrying out COVID-19 vaccinations (POR: 4,78). The government can carry out a reminder for the COVID-19 vaccination campaign. The Health Office can plan content about COVID-19 and the latest COVID-19 vaccinations and focus on spreading information through social media and updating data on vaccination achievements. The community is advised to remain vigilant and implement health protocols and carry out booster vaccinations for those who have not yet done it.
S-11204
Depok : FKM-UI, 2023
S1 - Skripsi Pusat Informasi Kesehatan Masyarakat
☉
Farchan Azzumar; Pembimbing: Ratna Djuwita; Penguji: Sudarto Ronoatmodjo, Dwi Oktavia, Erlina Burhan
Abstrak:
Read More
Varian Delta menyebabkan pelonjakan kasus COVID-19 di DKI Jakarta pada pertengahan tahun 2021. Sementara itu, vaksinasi COVID-19 yang dimulai pada Januari 2021 mengalami akselerasi pada pertengahan tahun 2021. Kedua kondisi ini memungkinakn terjadinya vaksinasi pada orang yang sedang terinfeksi SARS-CoV-2. Belum ada literatur ilmiah yang membahas respon imun tubuh manusia jika vaksinasi dan infeksi terjadi secara bersamaan. Penelitian ini menggunakan desain kohort retrospektif yang bertujuan untuk melihat dampak vaksinasi COVID-19 jika diberikan dalam 7 hari sebelum atau sesudah hari pengambilan sampel indeks. Hasilnya, pemberian 1 dosis vaksin COVID-19 masa infeksi akut berdampak pada proteksi terhadap kematian dalam 30 hari setelah tanggal pengambilan sampel indeks HR 0,32 (95%CI 0,11 – 0,48). Hasil penelitian ini memberikan pelajaran masa pandemi COVID-19 bahwa strategi vaksinasi pada saat sakit malah memberikan proteksi terhadap kematian.
The Delta variant caused a surge in COVID-19 cases in DKI Jakarta in mid-2021. Meanwhile, COVID-19 vaccinations, which began in January 2021, accelerated in mid-2021. These conditions made it possible for vaccination to occur in individuals who were currently infected with SARS-CoV-2. There is no scientific literature yet that discusses the human immune response when vaccination and infection occur simultaneously. This study uses a retrospective cohort design aimed at observing the impact of COVID-19 vaccination if administered within 7 days before or after the index sample collection date. The results show that administering a single dose of the COVID-19 vaccine during the acute infection period had a protective effect against death within 30 days after the index sample collection date, with an HR of 0.32 (95% CI 0.11 – 0.48). This study provides a lesson learnt from COVID-19 pandemic that evidence vaccination strategies during the acute infection may elicit protection against death.
T-7160
Depok : FKM UI, 2024
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉
Nessa Novarisa; Pembimbing: Helda; Penguji: Nurhayati Adnan, Gertrudis Tandy, Retno Henderiawati
Abstrak:
Read More
Setelah dicabutnya PPKM, terjadi peningkatan aktivitas sosial ekonomi masyarakat, yang dapat menyebabkan peningkatan kasus konfirmasi dan mortalitas COVID-19. Pemerintah telah melakukan vaksinasi COVID-19 untuk menurunkan mortalitas COVID-19 di Indonesia. DKI Jakarta sebagai ibu kota negara, menyumbangkan 16-17% perekonomian nasional, memiliki cakupan dosis boosternya masih rendah (53,9%). Penelitian ini menilai pengaruh status, homogenitas dan jenis vaksin booster secara kohort retrospektif menggunakan data Dinas Kesehatan DKI Jakarta 2023. Jumlah sampel 1069 partisipan dengan proporsi 17-45 tahun (44,62%), perempuan (56,03%), domisili DKI Jakarta (97,01%), tanpa komorbid (73,26%), mendapatkan booster (60,80%) booster heterolog (49,67%), luaran penelitian hidup (68,94%). Resiko kematian dipengaruhi oleh interaksi komorbiditas dengan status maupun jenis vaksin booster secara sinergisme. Proporsi kematian karena interaksi adalah 4,76%. Risiko kematian vaksin booster homolog 1,33 dibandingkan heterolog (0,83-2,13 p value 0,232). Pasien dengan komorbiditas dan tidak vaksin booster memiliki risiko kematian tertinggi ditinjau dari status vaksin booster (reference mendapat vaksin booster, RR 6,93 95% CI 5,07-9,48 dan p value = 0,000) maupun jenis vaksin booster (reference mendapat vaksin booster heterolog, RR 6,97 95% CI 4,98-9,76 dan p value = 0,000). Peneliti merekomendasikan pemberian vaksin booster, terutama heterolog booster, pada kelompok komorbid untuk mencegah kematian COVID-19.
After revocation of PPKM, socioeconomic activity increased, lead to escalation of confirmed cases and mortality COVID-19. The government conducted vaccination to reduce COVID-19 mortality in Indonesia. DKI Jakarta the nation's capital, contributing 16-17% of national economy, has only 53,9% booster dose coverage. This study assessed the influence of status, homogeneity and type of booster vaccine in retrospective cohort using DKI Jakarta Health Service 2023 data. The sample was 1069 with 17-45 years (44.62%), female (56.03%), domiciled in DKI Jakarta (97.01%), without comorbidities (73.26%), received booster (60.80%), heterologous booster (49.67%) and alive (68.94%). The mortality risk is influenced by interaction of comorbidities with status and type of booster vaccine synergistically. The proportion of deaths due to interactions was 4.76%. The mortality risk of homologous booster was 1.33 compared to heterologous (0.83-2.13 p value 0.232). Patients with comorbidities and no booster have the highest risk in terms of booster status (reference received booster, RR 6.93 95% CI 5.07-9.48 and p value = 0.000) and type (reference received vaccine heterologous booster, RR 6.97 95% CI 4.98-9.76 and p value = 0.000). Researchers recommend giving booster, especially heterologous, to comorbid groups to prevent COVID-19 deaths.
T-7031
Depok : FKM UI, 2024
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉
Apreh Ristanasari; Pembimbing: Wiku Bakti Bawono Adisasmito; Penguji: Prastuti Soewondo, Wachyu Sulistiadi, Suyono, Noviani
Abstrak:
Read More
Covid-19 berdampak pada berbagai aspek sehingga perlu upaya pengendalian. Selain melakukan protokol kesehatan maka perlu vaksinasi. Cakupan vaksinasi covid-19 dosis ketiga di Indonesia masih rendah sebesar 37,99%. Cakupan Provinsi Lampung masih rendah sebesar 28,58%. Provinsi Lampung juga berisiko tinggi apabila dilihat dari angka CFR covid-19 sebesar 5,59%. Berbagai strategi dilakukan untuk upaya percepatan vaksinasi dengan melibatkan berbagai aktor namun cakupan masih rendah. Dari studi pendahuluan diketahui bahwa terdapat hambatan pada unsur fungsi manajemen. Tujuan penelitian ini untuk mengidentifikasi manajemen program vaksinasi covid-19 dari penyedia layanan yang mempengaruhi cakupan vaksin covid-19 dosis ketiga. Penelitian ini menggunakan metode penelitian kualitatif dengan jenis penelitian Rapid Assesment Procedures (RAP). Hasil penelitian ini menunjukkan bahwa ada pengaruh aspek kontek meliputi pembiayaan, logistik vaksin, regulasi serta sarana dan prasarana terhadap cakupan vaksin covid-19 dosis ketiga. Terdapat pengaruh mekanisme dalam aktor meliputi pelaksanaan, pencatatan pelaporan, monitoring dan evaluasi serta koordinasi terhadap cakupan vaksin covid-19 dosis ketiga. Diketahui pada aspek hasil masih rendah yaitu rata-rata pemakaian vaksin perhari sebesar 277 dosis dan cakupan vaksin dosis ketiga sebesar 28,58%. Kesimpulan Peningkatan cakupan vaksinasi covid-19 dosis ketiga di Provinsi Lampung terkendala oleh manajemen program penyedia layanan terutama dari aspek pembiayaan, logistik vaksin, regulasi, koordinasi, pencatatan, dan pelaporan
Covid-19 has an impact on various aspects so it needs control efforts. In addition to carrying out health protocols, it is necessary to vaccinate. Coverage of the third dose of Covid-19 vaccination in Indonesia is still low at 37.99%. Lampung Province coverage is still low at 28.58%. Lampung Province is also at high risk when viewed from the CFR co-19 figure of 5.59%. Various strategies have been implemented to accelerate vaccination by involving various actors but the coverage is still low. From the preliminary study it is known that there are obstacles to the elements of the management function. The purpose of this study was to identify the management of the covid-19 vaccination program from service providers that affect coverage of the third dose of the covid-19 vaccine. This study used a qualitative research method with the type of Rapid Assessment Procedures (RAP) research. The results of this study indicate that there is an influence of context aspects including financing, vaccine logistics, regulations and facilities and infrastructure on the coverage of the third dose of the covid-19 vaccine. There is the influence of mechanisms within actors including implementation, recording of reporting, monitoring and evaluation as well as coordination of coverage of the third dose of the covid-19 vaccine. It is known that the yield aspect is still low, namely the average use of vaccine per day is 277 doses and the third dose vaccine coverage is 28.58%. Conclusion Increasing coverage of the third dose of covid-19 vaccination in Lampung Province is constrained by program management of service providers, especially from the aspects of financing, vaccine logistics, regulation, coordination, recording and reporting.
T-6651
Depok : FKM-UI, 2023
S2 - Tesis Pusat Informasi Kesehatan Masyarakat
☉